Clinical Utility of Fourth Generation AlereTM HIV P24 Core Antigen Rapid Combo Test Panels for Improved Detection of Human Immunodeficiency Virus Infection among Pre-Screened HIV 1 and 2 Antibody Sero-Negative Long-Distant Truck Drivers in Calabar Municipality, Cross River State, Nigeria


Authors : Forwah Jacques Ndeh; Akpan, Idongesit Samuel; Abeshi Sylvester Etenikang; Ochie Johnson Mba; Joshua Obase-Otumoyi Ofor; Ebot Walter Ojong; Otti Chidiebere Joel; Ezea Prosper Chiazam; Immaculate Ihuoma Ekeagba

Volume/Issue : Volume 9 - 2024, Issue 8 - August

Google Scholar : https://tinyurl.com/5n88hj2j

Scribd : https://tinyurl.com/2rm8fz2x

DOI : https://doi.org/10.38124/ijisrt/IJISRT24AUG703

Abstract : Recent studies have shown that transmission of human immunodeficiency virus (HIV) infection from infected but screened HIV antibody sero-negative individuals have continued to be a public challenge. This unprecedented finding may be due to the long pre- seroconvertion / window period or other predisposing factors like resource poor settings especially where there are no availability of ideal HIV p24 antigen /antibody fourth generation panels or biomarkers during early phase of this infection. The current study investigated HIV p24 core antigen status of healthy Long Distant Truck Drivers (LDTDs) of commercial and public vehicles, who were previously screened and documented as HIV antibody- sero-negative males with ages above 20 years in Calabar Municipality, Cross River State, Nigeria. About five milliliters of blood samples were collected from precounseled and consented 400 apparently healthy married and unmarried male participants who were initially screened for HIV 1 and 2 antibodies using DetermineTM HIV-1 and 2 (Inverness Medical Japan company limited ), Stat-Pak HIV-1 and 2 (Chembio Diagnostic System International Inco-operation ,United State of America) and HIV Uni-gold rapid test kit (Trinity Biotech, United State of American ) respectively and repeated for HIV p24 antigens screening using Alere TM HIV-1 and 2 p24 Ag/ Ab Combo test kit-tool ( Inverness Medical Japan company limited, United State America).After data analysis using IBM-SPSS version 26, about 12 (3%), 10 (2.5%) and 9 (2.25%) of participants were reactive to HIV 1 and 2 Determine, Stat-Pak and Unigold test panels respectively, with statistical significant difference between the results according to marital status (p=0.7065) and mean age range in years .While some of the 15 (3.75%), 12 (3.0%) and 10 (2.5%) participants who reacted to HIV 1 and 2 antibodies panels including the 388, 390 and 391 participants respectively who initially tested non-reactive for the three HIV antibody kits become reactive to HIV p24 core antigens with no statistically significant difference between the results of the three HIV 1& 2 antibody test kits and HIV p24 antigen/antibody tests (P=0.901).In the current study, the use of fourth generation AlereTM HIV P24 Core Antigen rapid test kit tool had not only improved detection of HIV infection in the index population but had also demonstrated the discrepancies, limitations and short-coming associated with the routine antibody screening testing panels when done alone in this population at early stage of HIV infection and long HIV window period.

Keywords : HIVI &II P24 Antigens Test Tool Kits , HIV 1 & II Antibody Screening Test Tool Kits , HIV 1 & II Antibody- Sero-Negative Screened Long-Distant Truck Drivers, Commercialized Private And Public Vehicle’s Terminals , Calabar Municipality.

References :

  1. Sharma V, Saggurti N, Bharat S. Health care coverage among long-distance truckers in India: an evaluation based on the Tanahashi model. HIV AIDS (Auckl). 2015;7:83-94 ,https://doi.org/10.2147/HIV.S76416.
  2. International Labour Organisation. Report and analysis of “A Truck Driver’s Life: Working Conditions and Sexual Health”. HIV and Long-distance Transport in Paraguay. Santiago: International Labour Organisation; http://www.ilo.org/wcmsp5/groups/public/@ed_protect/@protrav/@ilo_aids/documents/publication/wcms_184517.pdf. 2012. Accessed January 3, 2015.
  3. Singh YN, Malaviya AN. Long distance truck drivers in India: HIV infection and their possible role in disseminating HIV into rural areas. Int J STD AIDS. 1994;5(2):137–138
  4. The World Bank. Transport Against HIV/AIDS: Synthesis of Experience and Best Practice Guidelines. Washington, DC: The World Bank; 2009. Available from: http://siteresources.worldbank.org/INTTRANSPORT/Resources/336291-1227561426235/5611053-1229359963828/tp-25-HIV-AIDS.pdf. Accessed January 3, 2015.
  5. Chandrasekaran P, Dallabetta G, Loo V, Rao S, Gayle H, Alexander A. Containing HIV/AIDS in India: the unfinished agenda. Lancet Infect Dis. 2006;6(8):508–521.
  6. Rao KS, Pilli RD, Rao AS, Chalam PS. Sexual lifestyle of long distance lorry drivers in India: questionnaire survey. BMJ. 1999;318(7177):162–163.
  7. Hudson CP. AIDS in rural Africa: a paradigm for HIV-1 prevention. Int J STD AIDS. 1996;7(4):236–243.
  8. UNAIDS. (2009): The latest statistics of the global HIV and AIDS epidemic: published by UNAIDS in November, 2009, refer to the end of 2008.
  9. Imagawa, D.T., M.H. Lee. S.M Wolinsky (1989): Human immunod¬eficiency virus type 1 infection in homosexual men who remain sero-negative for prolonged periods. New England Journal of Medicine, 320: Pages 1458-1462.
  10. Larry Reimer Susan Mottice, Charles Schable, Patrick Sullivan, Allyn Nakashima, Mark   Rayfield, Randy Den, Charles Brokopp, Absence of Detectable Antibody in a Patient Infected with Human Immunodeficiency Virus in Clinical Infectious Diseases 1997;25:98–100
  11. Centers for Disease Control and Prevention (CDC), Persistent Lack of Detectable HIV-1 Antibody In a Person with HIV Infection -- Utah, Morbidity and Mortality Weekly Report (MMWR), 1996/45(09):181-8. [email protected]. Joseph Sonnabend, Natural Immunity and HIV journal of infection disease, 2010, 19/10/10   POZ.
  12. Egesie O.J, Joseph D.E, Egesie U.G, Odeh C.I., (2011): Trends in the incidence of hepatitis B, C and Human Immunodeficiency Virus among blood   donors in a tertiary hospital in Nigeria. Journal of Medicine in the Tropics.13 (1), (In press
  13. Coovadia H., (2004): Antiretroviral agents how best to protect infants from HIV and save their mothers from AIDS". New England Journal of Medicine 351 (3): Page 289–292.
  14. Zhu, T., Corey, L., Akridge, R., Change,Y., Feng F., Kim J. & Mcelrath J. (1999). Evidence for HIV-1 latent infection in exposed seronegative individuals.6thConference on Retroviruses and Opportunistic Infections. Chicago
  15. Zhu -Tuofu.  C. L., Hwangbo,Y ., Lee-J.M., Learn, G.H., Mullins,J.I., & McElrath, M J. (2003):Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. Journal of virology, 77(11):6108-16
  16. Wood, R.W., Dunphy, C., Okita. K., & Swenson, P. (2003). "Two "HIV-Infected" Persons Not Really Infected". Achieves of Internal Medicine, 163 (15):1857–1859
  17. Schattner, A., Hanuka, N., Sarov, B., Sarov, I., Handzel, Z.  & Bentwich Z.(1991). Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion. Clinical Experimental Immunology, 85:209-13.
  18. Lucie Seyler, Patrick Lacor, Sabine D Allard . Current challenges in the treatment of HIV, Pol Arch Intern Med. 2018, Oct 31, 128(10):609-616. 
  19. Ayesha B.M. Kharsany and Quarraisha A. Karim, HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities, Open AIDS J. 2016; 10: 34–48,  10.2174/1874613601610010034 
  20. Fadela Chaib and Tunga Namjilsuren, The World Health Organization (WHO) flags key challenges to global HIV response at International AIDS Conference, meets at the International AIDS Conference in Durban, South Africa, from 18–22 July 2016, Note for Media, Reading time: 4 min (989 words). https://www.who.int/news/item/14-07-2016-who-flags-key-challenges-to-global-hiv-response-at-international-aids-conference
  21. Simon Dixon,Scott McDonald,  Jennifer Roberts,,The impact of HIV and AIDS on Africa's economic development, BMJ. 2002 Jan 26; 324(7331): 232–234.
  22. Joses M Kirigia  , Luis G Sambo, Tuoyo Okorosobo, Germano M Mwabu ,Impact of HIV/AIDS on Gross Domestic Product (GDP) in the WHO Africa Region Afr J Health Sci . Jan-Jun 2002;9 (1-2):27-39
  23. Shongkour Roy , The effects of HIV/AIDS on economic growth and human capitals: a panel study evidence from Asian countries Multicenter Study AIDS Care. 2014;26 (12):1568-75.
  24. Helene D. Gayle and Gena L. Hill, Global Impact of Human Immunodeficiency Virus and AIDS, Clin Microbiol Rev. 2001 Apr; 14(2): 327–335.
  25. Jeffrey E. Harris, Why We Don’t Have An HIV Vaccine, And How We Can Develop One Meeting HIV/AIDS Costs; Fighting Neglected Diseases,  Health Affairs    November/December 2009, Vol. 28, No. 6:
  26. WHO GHO, 2020: World Health Organization Global Health Observatory data on HIV/AIDS 2020
  27. UNAIDS, 2020:  United Nation Joint Programme on AIDS, Global HIV/AIDS 2020 fact sheet.
  28. Fauci A., Masur H., Gelmann, E.P., Markham, P.O., Halin, B.H.and Lane H.C., (1985): The AIDS, an update annual of internal medicine 102:800-813Weiss RA (May 1993). "How does HIV cause AIDS? Science 260 (5112): 1273–9
  29. Douek D.C., Roederer M, Koup RA (2009). "Emerging concepts in the immunopathogenesis of AIDS". Annu. Rev. Med. 60: 471–84
  30. United Nation Joint Programme on AIDS ABUJA/GENEVA Declaration, 2020 Report
  31. Cross River State eMTCT Operation Plan for the Elimination of Mother -to- Child Transmission of HIV,  Bayelsa State Ministry of Health, Family Health International- FHI 360 and United Nation Joint Programme on AIDS   REPORT 2013-2015 .
  32. Osuchukwu N.C., A.A Onovo, A. O. Atobatcle, I. E Nta, (2013): Disproportionate Burden of HIV Prevalence among Men and Women assessing HIV Testing and Counseling Services in Cross River State Nigeria, IOSR Journal of Pharmacy and Biological Science (IOSR-JPBS) volume 7, issue 6 pp19-24.
  33. Wahdan M.H. (1995): Epidemiology of acquired immunodeficiency syndrome. Alexandria, World Health Organization, Regional Office for the Eastern Mediterranean, (WHO-EM/GPA/014/E/L/95).
  34. Barré-Sinoussi F., Chermann J.C., Rey F., (1983): Isolation of a T-lymphotropic retrovirus from a patient at risk For Acquired Immuno - Deficiency   syndrome (AIDS). Science 220: page 868-871.
  35. WHO, (2007): Guidelines for antimicrobial resistance surveillance. WHO Regional Publications. Eastern Mediterranean Series No. 151929021213, Border No. 1440015
  36. Alison Walkley, (2009): HIV transmission via transfusions in Africa remains  high,  MEDIAGLOBAL published by United Nations Secretariat, Room L-221 K, Dag Hammarskjold Library, New York, NY  10017.   http://mediaglobal.org/article/2009-08-08/cote-divoire-approved-for-fi. [PubMed] [Google Scholar]
  37. UNAIDS. (2009): The latest statistics of the global HIV and AIDS epidemic: published by UNAIDS in November, 2009, refer to the end of 2008.[PubMed] [Google Scholar]
  38. Jahun I, Dirlikov E, Odafe S, Yakubu A, Boyd AT, Bachanas P, Nzelu C, Aliyu G, Ellerbrock T, Swaminathan M. Ensuring Optimal Community HIV Testing Services in Nigeria Using an Enhanced Community Case-Finding Package (ECCP), October 2019–March 2020: Acceleration to HIV Epidemic Control. HIV AIDS (Auckl). 2021;13:839-850https://doi.org/10.2147/HIV.S316480
  39. Nwaozuru, U., Iwelunmor, J., Ong, J.J. et al. Preferences for HIV testing services among young people in Nigeria. BMC Health Serv Res 19, 1003 (2019). https://doi.org/10.1186/s12913-019-4847-x
  40. A. S. Sagay, J. Musa, A. S. Adewole, G. E. Imade, C. C. Ekwempu, S. Kapiga, J. L. Sankale, J. Idoko and P. Kanki (Apr., 2006) Rapid HIV Testing and Counselling in Labour in a Northern Nigerian Setting African Journal of Reproductive Health / La Revue Africaine de la Santé Reproductive Vol. 10, No. 1 , pp. 76-80 (5 pages) Published By: Women's Health and Action Research Centre (WHARC) https://doi.org/10.2307/30032446  https://www.jstor.org/stable/30032446
  41. National Population Commission (NPC) [Nigeria] and ICF Macro. 2009. Nigeria Demographic and Health Survey2008. Abuja, Nigeria:National Population Commission and ICF Macro.
  42. Cochran, W. G. (1977). Sampling techniques (3rd edtion.), 605 third Avenue, New York, New York, 10016 by John Wiley & Sons inc, ISBN0-471-02939-4
  43. Bartlett, J. E., II, Kortrijk, J. W. & Higgins, C. (2001)."Organizational research determining appropriate sample size for survey research", Information Technology, Learning, and Performance Journal, 19(1), 43- 50.
  44. Rao J.N.K., (2004): Sample size calaculation, by Rao soft, Internationa incooporation
  45. Ary, D., Jacobs, L. C., & Razavieh, A. (1996). Introduction to research in education. Fort Worth,TX: Harcourt Brace College Publishers.
  46. The National Institute for Occupational Safety and Health (NIOSH). Available at : https://www.cdc.gov/niosh/topics/truck/default.html
  47. Dembe, AE, Delbos, R, Erickson, JB. (2005) The impact of overtime and long work hours on occupational injuries and illnesses: new evidence from the United States. Occupational and Environmental Medicine 62(9): 588–597. Google Scholar | Crossref | Medline | ISI
  48. Beilock, R (1994) Schedule tightness and work hours of long-distance tractor trailer drivers in the United States. In: Canadian Transportation Research Forum. Victoria, BC, Canada: Canadian Transportation Research Forum, pp. 519–531. Google Scholar
  49. Federal Motor Carrier Safety Administration (FMCSA), US Department of Transportation (2005) 49) FMCSA Field HOS Survey: Motor Carrier Industry Implementation and Use of the April 2003 Hours of Service Regulations. Washington, DC: FMCSA, US Department of Transportation [Google Scholar].
  50. Michael H Belzer, Stanley A Sedo, Why do long distance truck drivers work extremely long hours?, First Published, September 18, 2017, Vol 29, Issue 1, 2018 Article Research, Available at: https://doi.org/10.1177/1035304617728440..
  51. Sunil S Solomon, Shruti H Mehta, Amanda Latimore, Aylur K Srikrishnan, David D Celentano  (2010 ): The impact of HIV and high-risk behaviours on the wives of married men who have sex with men and injection drug users: implications for HIV prevention .Avaible at : https://doi.org/10.1186/1758-2652-13-S2-S7.
  52. Augustin J. Kposowa, marital status and HIV /AIDS Mortality: Evidence from   the US National Longitudinal Mortality Study, International Journal of infectious Diseases, Volume17, Issue 10, (2013), Pages e868-e874.
  53. O. Shisana ,N. Zungu-Dirwayi, Y. Toefy, L. C. Simbayi, S. Mark, K.  Zuma , marital status and risk of HIV infection in South Africa, july 2004 ,Volume 94, No7 ,SAMJ.
  54. Scott, Patrick G. and Santa Falcone. 1998. “Comparing Public and Private. Organizations: An Exploratory Analysis of Three Frameworks,” American.
  55. Samuel Aryee, Public and Private Sector Professionals: A Comparative Study of their Perceived Work Experience First Published Mar 1, 1992; pp. 72–85. Available at: https://doi.org/10.1177/1059601192171006
  56. Samuel Aryee, Dail Fields, Vivienne Luk A Cross-Cultural Test of a Model of the Work-Family Interface First Published August 1, 1999 Research Article. Available at: https://doi.org/10.1177/014920639902500402
  57. WHO,2021, the  release of  new toolkit to support quality of HIV testing services, department  news .
  58. Olive Shisana, Kathryn Risher, David D Celentano, Nompumelelo Zungu, Thomas Rehle, Busani Ngcaweni, Meredith GB EvansDoes marital status matter in an HIV hyperendemic country? Findings from the 2012 South African National HIV Prevalence, Incidence and Behaviour Survey AIDS Care. Author manuscript; available in PMC 2017 Jan 1.Published in final edited form as: AIDS Care. 2016; 28(2): 234–241. Published online 2015 Nov 9. doi: 10.1080/09540121.2015.1080790 PMCID: PMC5146982
  59. Nabukenya, A.M., Nambuusi, A. & Matovu, J.K.B. Risk factors for HIV infection among married couples in Rakai, Uganda: a cross-sectional study. BMC Infect Dis 20, 198 (2020). Available at: https://doi.org/10.1186/s12879-020-4924-0.
  60. Jonathan Peter E, Experiences of Married Men with HIV during the Early Phase of Diagnosis within the Context of Mandatory Disclosure: A Literature Review,Journal of AIDS Clinical Research & STDs  Category: Clinical  Type: Review Article.
  61. Glenda Roberta Oliveira Naiff Ferreira, Ingrid Saraiva de Oliveira, Wanne Letícia Santos Freitas, Ana Luisa Brandão de Carvalho Lira, Renata Karina Reis, Elucir Gir, Aline Maria Pereira Cruz Ramos, Lucia Hisako Takase Gonçalves, Eliã Pinheiro Botelho ,2021,Factors associated with low knowledge about sexually transmitted infections in subnormal agglomerate, in the Brazilian Amazon,Prim Health Care Res Dev. 2021; 22: e70. Published online 2021 Nov 12. doi: 10.1017/S1463423621000700 PMCID: PMC8628559.
  62. Rose Kisa, Joseph K. B. Matovu, Esther Buregyeya, William Musoke, Caroline J. Vrana-Diaz, Jeffrey E. Korte, Rhoda K. Wanyenze ,Repeat HIV testing of individuals with discrepant HIV self-test results in Central Uganda AIDS Res Ther. 2019; 16: 26. Published online 2019 Sep 12. doi: 10.1186/s12981-019-0243-1,PMCID  PMC6739989.
  63. Tania Crucitti, Doug Taylor, Greet Beelaert, Katrien Fransen, Lut Van DammePerformance of a Rapid and Simple HIV Testing Algorithm in a Multicenter Phase III Microbicide Clinical TrialClin Vaccine Immunol. 2011 Sep; 18(9): 1480–1485. doi: 10.1128/CVI.05069-11PMCID:   PMC3165239.
  64. Mars Stone, John Bainbridge, Ana M. Sanchez, Sheila M. Keating, Andrea Pappas, Wes Rountree, Chris Todd, Sonia Bakkour, Mark Manak, Sheila A. Peel, Robert W. Coombs, Eric M. Ramos, M. Kathleen Shriver, Paul Contestable, Sangeetha Vijaysri Nair, David H. Wilson, Martin Stengelin, Gary Murphy, Indira Hewlett, Thomas N. Denny, Michael P. BuschComparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates, J Clin Microbiol. 2018 Aug; 56(8): e02045-17. Prepublished online 2018 May 23. Published online 2018 Jul 26. doi: 10.1128/JCM.02045-17PMCID: PMC6062817.
  65. Karl Stefic, Jerome Guinard, Gilles Peytavin, Leïla Saboni, Cécile Sommen, Claire Sauvage, Florence Lot, Syria Laperche, Annie Velter, Francis Barin,Screening for Human Immunodeficiency Virus Infection by Use of a Fourth-Generation Antigen/Antibody Assay and Dried Blood Spots: In-Depth Analysis of Sensitivity and Performance Assessment in a Cross-Sectional Study,J Clin Microbiol. 2020 Jan; 58(1): e01645-19. Prepublished online 2019 Oct 30. Published online 2019 Dec 23. doi: 10.1128/JCM.01645-19.PMCID: PMC6935938.
  66. Peter Liu, Patrick Jackson, Nathan Shaw, Scott Heysell, Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests,AIDS Res Ther. 2016; 13: 1. Published online 2016 Jan 5. doi: 10.1186/s12981-015-0086-3 PMCID  PMC4700595.
  67. USAID, FHI360 commend Cross River government on reducing HIV prevalence,November 8, 2021,Vanguard Media Limited, Nigeria.https://www.vanguardngr.com/2021/11/usaid-fhi360-commend-cross-river-government-on-reducing-hiv-prevalence/.
  68. National agency for the control of AIDS , on the current prevalence rate ,cross river state branch . Avaialable at :  https://naca.gov.ng/nigeria-prevalence-rate/
  69. UNAIDS Nigeria, 2021 HIV statistics data. Available at:  https://www.unaids.org/en/regionscountries/countries/Nigeria.
  70. Family Health International (FHI) 360 2021: commend Cross River government on reducing HIV prevalence.
  71. Centers for Disease Control and Protection. "HIV/AIDS acts".
  72. Adedotun A Adetunji, Modupe Akinrele Kuti, RA Audu, Sufiyan Abu Muyibi,Discordant rapid HIV tests: Lessons from a low-resource community , July 2017,HIV Medicine 19 (1), DOI:10.1111/hiv.12541
  73. Trevethan R (2017) Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice. Front. Public Health 5:307. doi: 10.3389/fpubh.2017.00307.
  74. Grunau, G. L., and Linn, S. (2018): A Commentary on : Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice Front. Public Health 6:256. doi: 10.3389/fpubh.2018.00256.
  75. Kimmig P. Sensitivität und Spezifität von Untersuchungsverfahren bei HIV [Sensitivity and specificity of test results in HIV]. Offentl Gesundheitswes. 1990 Aug-Sep;52(8-9):419-24. German. PMID: 2146552.
  76. Raymond Boadu, George Darko, Priscilla Nortey, Patricia Akweongo, Bismark Sarfo, Assessing the sensitivity and specificity of First Response HIV-1-2 test kit with whole blood and serum samples: a cross-sectional study, AIDS Res Ther. 2016; 13: 9. Published online 2016 Feb 16. doi: 10.1186/s12981-016-0092-0PMCID  PMC4756447.
  77. Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, Karugaba P, Panchia R, Marrazzo J, Chirenje ZM, Parikh UM; VOICE Study Team. The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017 Sep;94:15-21. doi: 10.1016/j.jcv.2017.06.006. Epub 2017 Jun 29. PMID: 28710996; PMCID: PMC5790424.

Recent studies have shown that transmission of human immunodeficiency virus (HIV) infection from infected but screened HIV antibody sero-negative individuals have continued to be a public challenge. This unprecedented finding may be due to the long pre- seroconvertion / window period or other predisposing factors like resource poor settings especially where there are no availability of ideal HIV p24 antigen /antibody fourth generation panels or biomarkers during early phase of this infection. The current study investigated HIV p24 core antigen status of healthy Long Distant Truck Drivers (LDTDs) of commercial and public vehicles, who were previously screened and documented as HIV antibody- sero-negative males with ages above 20 years in Calabar Municipality, Cross River State, Nigeria. About five milliliters of blood samples were collected from precounseled and consented 400 apparently healthy married and unmarried male participants who were initially screened for HIV 1 and 2 antibodies using DetermineTM HIV-1 and 2 (Inverness Medical Japan company limited ), Stat-Pak HIV-1 and 2 (Chembio Diagnostic System International Inco-operation ,United State of America) and HIV Uni-gold rapid test kit (Trinity Biotech, United State of American ) respectively and repeated for HIV p24 antigens screening using Alere TM HIV-1 and 2 p24 Ag/ Ab Combo test kit-tool ( Inverness Medical Japan company limited, United State America).After data analysis using IBM-SPSS version 26, about 12 (3%), 10 (2.5%) and 9 (2.25%) of participants were reactive to HIV 1 and 2 Determine, Stat-Pak and Unigold test panels respectively, with statistical significant difference between the results according to marital status (p=0.7065) and mean age range in years .While some of the 15 (3.75%), 12 (3.0%) and 10 (2.5%) participants who reacted to HIV 1 and 2 antibodies panels including the 388, 390 and 391 participants respectively who initially tested non-reactive for the three HIV antibody kits become reactive to HIV p24 core antigens with no statistically significant difference between the results of the three HIV 1& 2 antibody test kits and HIV p24 antigen/antibody tests (P=0.901).In the current study, the use of fourth generation AlereTM HIV P24 Core Antigen rapid test kit tool had not only improved detection of HIV infection in the index population but had also demonstrated the discrepancies, limitations and short-coming associated with the routine antibody screening testing panels when done alone in this population at early stage of HIV infection and long HIV window period.

Keywords : HIVI &II P24 Antigens Test Tool Kits , HIV 1 & II Antibody Screening Test Tool Kits , HIV 1 & II Antibody- Sero-Negative Screened Long-Distant Truck Drivers, Commercialized Private And Public Vehicle’s Terminals , Calabar Municipality.

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe